Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies

被引：0
|
作者：
Shimoni, Avichai [1 ]
Hardan, Izhar [1 ]
Rand, Avital [1 ]
Shem-Tov, Noga [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：596A / 596A
页数：1
相关论文
共 50 条
  • [21] Impact of age on outcome of reduced-intensity conditioning with fludarabine and busulfan for allogeneic haematopoietic cell transplantation
    Schneidawind, D.
    Federmann, B.
    Helwig, A.
    Vogel, W.
    Faul, C.
    Kanz, L.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S230 - S230
  • [22] Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Kamijo, Kimimori
    Shimomura, Yoshimitsu
    Kim, Sung-Won
    Ara, Takahide
    Ishikawa, Jun
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Mizuno, Ishikazu
    Kusumoto, Shigeru
    Ueda, Yasunori
    Matsuoka, Ken-ichi
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kondo, Eisei
    BLOOD, 2022, 140 : 2393 - 2394
  • [23] Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS
    Kennedy, GA
    Butler, J
    Durrant, S
    Hill, GR
    Western, R
    Morton, J
    BLOOD, 2005, 106 (11) : 438B - 439B
  • [24] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Stein, A.
    Naing, A.
    Tsai, N.
    Chang, K.
    Slovak, M. L.
    Bhatia, R.
    Spielberger, R.
    Kogut, N.
    Pullarkat, V.
    Kirschbaum, M.
    Forman, S. J.
    O'Donnell, M. R.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 843 - 850
  • [25] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    Yerushalmi, R.
    Shem-Tov, N.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shinnoni, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1526 - 1535
  • [26] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    R Yerushalmi
    N Shem-Tov
    I Danylesko
    A Avigdor
    A Nagler
    A Shimoni
    Bone Marrow Transplantation, 2015, 50 : 1526 - 1535
  • [27] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    R Nakamura
    R Rodriguez
    J Palmer
    A Stein
    A Naing
    N Tsai
    K Chang
    M L Slovak
    R Bhatia
    R Spielberger
    N Kogut
    V Pullarkat
    M Kirschbaum
    S J Forman
    M R O'Donnell
    Bone Marrow Transplantation, 2007, 40 : 843 - 850
  • [28] Allogeneic stem cell transplantation for patients with advanced hematological malignancies: Comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
    Kim, Inho
    Lee, Kyung-Hun
    Choi, Yunhee
    Keam, Bhumsuk
    Koo, Nam Hee
    Yoon, Sung-Soo
    Yoo, Keun-Young
    Park, Seonyang
    Kim, Byoung Kock
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (02) : 227 - 234
  • [29] Fludarabine, Low Dose Busulfan and Antithymocyte Globulin for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT)
    Malard, F.
    Brissot, Eolia
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Le Gouill, Steven
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harousseau, Jean-Luc
    Moreau, Philippe
    Milpied, Noel-Jean
    Mohty, Mohamad
    BLOOD, 2009, 114 (22) : 1296 - 1297
  • [30] Thiotepa and fludarabine as reduced-intensity conditioning regimen followed by allogeneic peripheral stem cell transplantation for hematologic malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Varettoni, M
    Rumi, E
    Baraté, C
    Ardizzone, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S155 - S155
12345